Market Cap 162.21B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.17
Forward PE 9.39
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 39,265,853
Avg Vol 42,519,547
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 63%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
TalkMarkets
TalkMarkets Sep. 2 at 11:26 PM
Did The #COVID Vaccine Ruin #Pfizer’s 6.1% Yield? $PFE https://talkmarkets.com/article/did-the-covid-vaccine-ruin-pfizers-61-yield-1788391565
0 · Reply
CapitalMonk
CapitalMonk Sep. 2 at 10:24 PM
$PFE Price: $29.02 (+1.65%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.57% RSI: 77.5 | Momentum: Moderate Volume: +3.3% vs avg Volatility: 1.44% Support: $25.30 | Resistance: $29.09 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:20 PM
$IBRX $MRNA $MRK $PFE $JNJ https://x.com/stkirsch/status/2094989788919267745?s=46
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:12 PM
$IBRX $MRNA.X $MRK $PFE $JNJ …alotta opinions on Makis, but WOW! https://x.com/makismedicine/status/2095156284513284405?s=46
1 · Reply
SniperPro
SniperPro Sep. 2 at 8:12 PM
$LXRX $NVO $VTRS $PFE $MRK 🤔 Who’s going to be Lexicon’s next partner? With Lexicon Pharmaceuticals building momentum and its pipeline attracting attention, the big question is: who could be next to partner with Lex? Could it be $NVO $VTRS $PFE or $MRK ? The right partnership could be a major catalyst for $LXRX. 👀 Speculation for now—but it’s definitely worth watching closely. Who do you think is next? 🔥 Why are shorts covering? What do they know? TICK TOCK!!!!
0 · Reply
goguryo2000
goguryo2000 Sep. 2 at 8:07 PM
$PFE This is 3rd time it hit 29 and first time ended with 29 mark. 30 might come sooner than expected. Looking forward to see good old 35s and 36s.
0 · Reply
alexquick123
alexquick123 Sep. 2 at 7:47 PM
0 · Reply
Stockmaster198
Stockmaster198 Sep. 2 at 7:41 PM
$PFE it’s confirmed after market closed this will run past 100%
0 · Reply
Sb2001
Sb2001 Sep. 2 at 7:26 PM
$PFE sloooowly I step, inch by inch.
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 2 at 7:20 PM
$AZN $JNJ $MRK $PFE $SLS Shorts are pushing Dr. Stergiou to the brink and he might potentially release the GPS CURATIVE KRAKEN after the bell and wipe out cancer along with the shorts! ✌️🙏❤️‍🩹
0 · Reply
Latest News on PFE
Trump administration to announce drug pricing deals

Aug 31, 2026, 12:09 PM EDT - 2 days ago

Trump administration to announce drug pricing deals

AMGN LLY TAK


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 4 weeks ago

Pfizer Post Loss on Higher Revenue


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 1 month ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


TalkMarkets
TalkMarkets Sep. 2 at 11:26 PM
Did The #COVID Vaccine Ruin #Pfizer’s 6.1% Yield? $PFE https://talkmarkets.com/article/did-the-covid-vaccine-ruin-pfizers-61-yield-1788391565
0 · Reply
CapitalMonk
CapitalMonk Sep. 2 at 10:24 PM
$PFE Price: $29.02 (+1.65%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.57% RSI: 77.5 | Momentum: Moderate Volume: +3.3% vs avg Volatility: 1.44% Support: $25.30 | Resistance: $29.09 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:20 PM
$IBRX $MRNA $MRK $PFE $JNJ https://x.com/stkirsch/status/2094989788919267745?s=46
0 · Reply
Outcomes
Outcomes Sep. 2 at 9:12 PM
$IBRX $MRNA.X $MRK $PFE $JNJ …alotta opinions on Makis, but WOW! https://x.com/makismedicine/status/2095156284513284405?s=46
1 · Reply
SniperPro
SniperPro Sep. 2 at 8:12 PM
$LXRX $NVO $VTRS $PFE $MRK 🤔 Who’s going to be Lexicon’s next partner? With Lexicon Pharmaceuticals building momentum and its pipeline attracting attention, the big question is: who could be next to partner with Lex? Could it be $NVO $VTRS $PFE or $MRK ? The right partnership could be a major catalyst for $LXRX. 👀 Speculation for now—but it’s definitely worth watching closely. Who do you think is next? 🔥 Why are shorts covering? What do they know? TICK TOCK!!!!
0 · Reply
goguryo2000
goguryo2000 Sep. 2 at 8:07 PM
$PFE This is 3rd time it hit 29 and first time ended with 29 mark. 30 might come sooner than expected. Looking forward to see good old 35s and 36s.
0 · Reply
alexquick123
alexquick123 Sep. 2 at 7:47 PM
0 · Reply
Stockmaster198
Stockmaster198 Sep. 2 at 7:41 PM
$PFE it’s confirmed after market closed this will run past 100%
0 · Reply
Sb2001
Sb2001 Sep. 2 at 7:26 PM
$PFE sloooowly I step, inch by inch.
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 2 at 7:20 PM
$AZN $JNJ $MRK $PFE $SLS Shorts are pushing Dr. Stergiou to the brink and he might potentially release the GPS CURATIVE KRAKEN after the bell and wipe out cancer along with the shorts! ✌️🙏❤️‍🩹
0 · Reply
BB_88_
BB_88_ Sep. 2 at 7:14 PM
0 · Reply
WuTangClam
WuTangClam Sep. 2 at 6:58 PM
$PFE & $KHC $VZ .. dividend pick ups that were hard to miss with their monster dividends. Hopefully everybody was listening
0 · Reply
BWinner
BWinner Sep. 2 at 6:53 PM
$PFE $29!!!!!
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Sep. 2 at 6:50 PM
$PFE Really thought id sell the next time we got back here. But here I am deciding to stay. I have learned nothing and I am ready to get hurt again!
3 · Reply
jrh34
jrh34 Sep. 2 at 5:58 PM
$PFE Hot stock lately, let's see them get a deal on with $CRDF for Onvansertib in mCRC.
0 · Reply
zustrelaax
zustrelaax Sep. 2 at 5:56 PM
$PFE need catalyst to move 32 and next 36
0 · Reply
Fliptax
Fliptax Sep. 2 at 5:51 PM
$PFE $33-35 next stop
0 · Reply
jrh34
jrh34 Sep. 2 at 5:33 PM
$PFE is back in favor, which means $45-50 range is obtainable over the coming months.
0 · Reply
Willieberich
Willieberich Sep. 2 at 5:28 PM
$PFE break 29 on the close 30 is coming right away
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Sep. 2 at 5:08 PM
$PFE Nicely grinding towards those 30's again and believe the mid-30's is solid hold target and collect that +6-7% dividend depending on price entry! Technicals all looking very solid - some positive news will definitely lift this as well!
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 2 at 5:01 PM
$AZN $JNJ $MRK $PFE $SLS What does this mean for Big Pharmaceutical Suitors? GPS Curative 3 year plus Maintenance schedule for potentially 20+ WT1 cancers= $50 Billion annual peek sales and Dethrone patent expiring 2028 Keytruda as # 1 selling drug on the planet. ✌️🙏❤️‍🩹
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Sep. 2 at 4:57 PM
$SLS $JNJ $AZN $MRK $PFE The real breakthrough is dual MHC Class I and Class II activation. Multivalency also ensures the cancer can't run. Together, they create a self-sustaining, polyclonal, living defense system inside the patient, one that hunts WT1-expressing cells for the rest of their life. And the 80% GPS responders? They aren't likely just surviving. They are functionally cured. Not managed. Not in fragile remission. CURED. With infinite dosing their T cells are still patrolling YEARS later. No cytokine storms. No need for a donor search. An off-the-shelf injection that reprograms immunity itself. ✌️🙏❤️‍🩹
0 · Reply